US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 25.600
  • -0.860-3.25%
Close Jul 24 16:00 ET
  • 25.250
  • -0.350-1.37%
Post 18:00 ET
2.47BMarket Cap-4767P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.51%
ARK Holdings
ARK Holdings
Intraday-10.23%